조산 및 조기양막파수 검사 시장 규모, 점유율, 성장 분석 : 제품 유형별, 검사 유형별, 기술별, 용도별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Preterm Birth And Prom Testing Market size was valued at USD 1.8 Billion in 2024 and is poised to grow from USD 1.94 Billion in 2025 to USD 3.45 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The preterm birth and PROM testing market is driven by the urgent need for early identification of membrane rupture and preterm labor, influenced by rising preterm rates, advancing maternal age, and increased assisted reproduction practices. This market encompasses various diagnostic tools, including point-of-care lateral flow assays, biomarker panels, and imaging techniques used in prenatal and emergency settings. The shift towards biomarker assays and molecular diagnostics has enabled faster, more reliable diagnoses, thus reducing neonatal morbidity and intensive care costs. Technological innovation in rapid diagnostics enhances clinical efficiency and reduces unnecessary interventions. Additionally, AI advancements are elevating diagnostic accuracy by analyzing complex data patterns, improving risk stratification, and fostering timely clinician support, ultimately driving payer interest and broader implementation in healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preterm Birth And Prom Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preterm Birth And Prom Testing Market Segments Analysis

Global preterm birth and prom testing market is segmented by product type, test type, technology, application, end user, distribution channel and region. Based on product type, the market is segmented into Biomarker Test Kits, Rapid Diagnostic Tests, Instruments & Analyzers and Consumables & Reagents. Based on test type, the market is segmented into PROM Tests, Fetal Fibronectin (fFN) Tests, PAMG-1 Tests, IGFBP-1 Tests and Others. Based on technology, the market is segmented into Immunoassay-Based Testing, Lateral Flow Assays, Molecular Diagnostics and Point-of-Care Testing. Based on application, the market is segmented into Preterm Labor Risk Assessment, Premature Rupture of Membranes Detection, Pregnancy Monitoring and Obstetric Emergency Assessment. Based on end user, the market is segmented into Hospitals, Maternity Clinics, Diagnostic Laboratories and Ambulatory Care Centers. Based on distribution channel, the market is segmented into Direct Sales, Distributors and Online Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preterm Birth And Prom Testing Market

One of the key market drivers for the global preterm birth and PROM (premature rupture of membranes) testing market is the increasing prevalence of preterm births worldwide. Factors such as maternal age, lifestyle choices, and health conditions contribute to the rising incidence of preterm deliveries, necessitating the need for effective diagnostic tools and testing solutions. Enhanced awareness about the complications associated with preterm births pushes healthcare providers and expectant mothers to seek preventive measures and early interventions, thus driving demand for advanced diagnostic tests. Furthermore, ongoing research and technological advancements in prenatal care are likely to bolster market growth by providing more accurate and reliable testing options.

Restraints in the Global Preterm Birth And Prom Testing Market

A significant market restraint in the Global Preterm Birth and PROM Testing Market is the high costs associated with advanced diagnostic technologies and treatments. The financial burden these innovations impose can limit accessibility for many healthcare providers and patients, particularly in low- and middle-income regions where budget constraints are prevalent. Additionally, the lack of reimbursement policies for certain tests and treatments may deter healthcare professionals from adopting these solutions, further stalling market growth. This economic factor coupled with the variability in healthcare infrastructure across different regions continues to pose a challenge to the widespread implementation of preterm birth and PROM screening solutions.

Market Trends of the Global Preterm Birth And Prom Testing Market

The Global Preterm Birth and PROM Testing market is witnessing a significant trend towards the adoption of point-of-care (POC) diagnostic platforms. This rapid decentralization of testing is enhancing clinical decision-making and streamlining patient management in prenatal and emergency settings. Healthcare providers are increasingly favoring user-friendly assays that seamlessly integrate into existing workflows to generate actionable results during consultations. Consequently, collaborations between device manufacturers and care providers are on the rise, promoting broader access in community clinics. This trend not only supports enhanced patient care but also drives investments in user training, quality control, and reimbursement models, reinforcing the routine screening for preterm birth risks and membrane rupture.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Preterm Birth And PROM Testing Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Biomarker Test Kits
• Rapid Diagnostic Tests
• Instruments & Analyzers
• Consumables & Reagents

Global Preterm Birth And PROM Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• PROM Tests
• Fetal Fibronectin (fFN) Tests
• PAMG-1 Tests
• IGFBP-1 Tests
• Others

Global Preterm Birth And PROM Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassay-Based Testing
• Lateral Flow Assays
• Molecular Diagnostics
• Point-of-Care Testing

Global Preterm Birth And PROM Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Preterm Labor Risk Assessment
• Premature Rupture of Membranes Detection
• Pregnancy Monitoring
• Obstetric Emergency Assessment

Global Preterm Birth And PROM Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Maternity Clinics
• Diagnostic Laboratories
• Ambulatory Care Centers

Global Preterm Birth And PROM Testing Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors
• Online Sales

Global Preterm Birth And PROM Testing Market Size & CAGR (2026-2033)

• North America (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sera Prognostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NX Prenatal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQ Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosynex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Innovations
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medix Biochemica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laborie Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations